![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10528-013-9599-4/MediaObjects/10528_2013_9599_Fig1_HTML.gif)
References
Andreas K, Haupl T, Lubke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C (2009) Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther 11:R15
Bamford J, Dennis M, Sandercock P, Burn J, Warlow C (1990) The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 53:824–829
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526
Bessler H, Osovsky M, Beilin B, Alcalay Y, Sirota L (2007) The existence of gender difference in IL-1Ra gene polymorphism. J Interferon Cytokine Res 27:931–935
Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994) Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37:1380–1385
Castillo J, Alvarez-Sabin J, Martinez-Vila E, Montaner J, Sobrino T, Vivancos J (2009) Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol 256:217–224
Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P (1995) Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154:1432–1439
Cvetkovic JT, Wiklund PG, Ahmed E, Weinehall L, Hallmans G, Lefvert AK (2005) Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case-control study of their association with risk for stroke. J Stroke Cerebrovasc Dis 14:29–35
Dinarello CA (2000) The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343:732–734
Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196–2200
Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW (1999) Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861–866
Haneda S, Nagaoka K, Nambo Y, Kikuchi M, Nakano Y, Matsui M, Miyake Y, Macleod JN, Imakawa K (2009) Interleukin-1 receptor antagonist expression in the equine endometrium during the peri-implantation period. Domest Anim Endocrinol 36:209–218
Hurme M, Lahdenpohja N, Santtila S (1998) Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30:469–473
Hyams JS, Fitzgerald JE, Wyzga N, Treem WR, Justinich CJ, Kreutzer DL (1994) Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. Dig Dis Sci 39:1893–1899
Kang DW, Yoo SH, Chun S, Kwon KY, Kwon SU, Koh JY, Kim JS (2009) Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke 40:1653–1658
Kashyap RS, Nayak AR, Deshpande PS, Kabra D, Purohit HJ, Taori GM, Daginawala HF (2009) Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clin Chim Acta 402:160–163
Kriz J, Lalancette-Hebert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497–509
Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R, Lang W, Wagner O, Cheng S, Mannhalter C (2006) Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 44:918–923
Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MYI (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517–1526
Lennard A, Gorman P, Carrier M, Griffiths S, Scotney H, Sheer D, Solari R (1992) Cloning and chromosome map** of the human interleukin-1 receptor antagonist gene. Cytokine 4:83–89
Lindsberg PJ, Grau AJ (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34:2518–2532
Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106:637–642
Markus HS, Labrum R, Bevan S, Reindl M, Egger G, Wiedermann CJ, Xu Q, Kiechl S, Willeit J (2006) Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 37:2253–2259
Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195–198
Seripa D, Dobrina A, Margaglione M, Matera MG, Gravina C, Vecile E, Fazio VM (2003) Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis 15:276–281
Skinner RA, Gibson RM, Rothwell NJ, Pinteaux E, Penny JI (2009) Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 156:1115–1123
Steinbrugger I, Haas A, Maier R, Renner W, Mayer M, Werner C, Wedrich A, El-Shabrawi Y, Schmut O, Weger M (2009) Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion. Mol Vis 15:609–618
Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK (1988) Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) 296:1156–1160
Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403–404
Tso AR, Merino JG, Warach S (2007) Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 38:3070–3075
Weyrich AS, Skalabrin EJ, Kraiss LW (2009) Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Am J Ther 16:164–170
Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34:204–209
Wood PH (1980) Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron 34:376–380
Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL, DeGraba TJ (2003) Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34:790–793
Worrall BB, Brott TG, Brown RD Jr, Brown WM, Rich SS, Arepalli S, Wavrant-De Vrieze F, Duckworth J, Singleton AB, Hardy J, Meschia JF (2007) IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations. Stroke 38:1189–1196
Xu S, Huang W, Qian J, ** L (2008) Analysis of genomic admixture in Uyghur and its implication in map** strategy. Am J Hum Genet 82:883–894
Yamada Y, Ichihara S, Nishida T (2008) Proinflammatory gene polymorphisms and ischemic stroke. Curr Pharm Des 14:3590–3600
Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl G (2005) Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol 25:1519–1523
Acknowledgments
We are grateful to all participants of this study, and we thank Dongfeng Gu and Katherine A. Mason for their technical assistance and language help.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Y Tong, J Han, and X Guan contributed equally to this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tong, Y., Han, J., Guan, X. et al. Association of IL-1 Receptor Antagonist Gene VNTR Polymorphism with Ischemic Stroke in the Chinese Uyghur Population. Biochem Genet 51, 698–706 (2013). https://doi.org/10.1007/s10528-013-9599-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-013-9599-4